Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01899521 · ClinicalTrials.gov registry record · NA
Examination of Zinc, S-adenosylmethionine, and Combination Therapy Versus Placebo in Alcoholics
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
NCT01899521: Completed NA study, sponsored by VA Office of Research and Development.
NCT01899521 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 113 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01899521, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
Study Summary
This is a randomized, placebo controlled trial of dietary zinc and S-adenosylmethionine (SAMe) in otherwise healthy alcoholic US Veterans. The primary goal is to determine if either dietary zinc or S-adenosylmethionine (SAMe) can augment lung immune defenses in alcoholics and thereby decrease the risk of lung injury and infection.
Interventions
- PROCEDURE Bronchoscopy
- DIETARY_SUPPLEMENT Zinc sulfate 220 mg once daily
- DIETARY_SUPPLEMENT S-adenosylmethionine 400 mg twice daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2013-05-01 |
| Est. Completion | 2017-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01899521
The ClinicalTrials.gov registry entry for NCT01899521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bronchoscopy is the first listed.
NCT01899521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01899521 about?
NCT01899521 is a clinical study titled "Examination of Zinc, S-adenosylmethionine, and Combination Therapy Versus Placebo in Alcoholics". This is a randomized, placebo controlled trial of dietary zinc and S-adenosylmethionine (SAMe) in otherwise healthy alcoholic US Veterans. The primary goal is to determine if either dietary zinc or S-adenosylmethionine (SAMe) can augment lung immune defenses in alcoholics and thereby decrease the ri...
What is the current status of trial NCT01899521?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2013-05-01. Estimated completion is 2017-07-31.
What interventions are being tested in trial NCT01899521?
The interventions under investigation include: Bronchoscopy (PROCEDURE), Zinc sulfate 220 mg once daily (DIETARY_SUPPLEMENT), S-adenosylmethionine 400 mg twice daily (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01899521?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.